These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19473280)

  • 1. Validation of the Portuguese version of ID-Migraine.
    Gil-Gouveia R; Martins I
    Headache; 2010 Mar; 50(3):396-402. PubMed ID: 19473280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A validation study of an Italian version of the "ID Migraine".
    Brighina F; Salemi G; Fierro B; Gasparro A; Balletta A; Aloisio A; La Pegna G; Randisi G; Saporito V; Calagna G; La Naia F; Morana R
    Headache; 2007 Jun; 47(6):905-8. PubMed ID: 17578542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics.
    Ertaş M; Baykan B; Tuncel D; Gökçe M; Gökçay F; Sirin H; Deniz O; Oztürk V; Idiman F; Karli N; Zarifoğlu M; Yildiz N; Siva A; Saip S; Göksan B; Ak F; Aluçlu U; Duman T; Melek IM; Bulut S; Berilgen S;
    Cephalalgia; 2009 Jan; 29(1):68-75. PubMed ID: 18771489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the ID-Migraine screener in the workplace.
    Siva A; Zarifoglu M; Ertas M; Saip S; Karli HN; Baykan B; Keskinaslan A; Senocak M
    Neurology; 2008 Apr; 70(16):1337-45. PubMed ID: 18413587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine in adolescents: validation of a screening questionnaire.
    Valentinis L; Valent F; Mucchiut M; Barbone F; Bergonzi P; Zanchin G
    Headache; 2009 Feb; 49(2):202-11. PubMed ID: 19222594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can ID Migraine be used as a screening test for adolescent migraine?
    Zarifoğlu M; Karli N; Taşkapilioğlu O
    Cephalalgia; 2008 Jan; 28(1):65-71. PubMed ID: 17986273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.
    Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M;
    Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a brief nurse-administered migraine assessment tool.
    Marcus DA; Kapelewski C; Jacob RG; Rudy TE; Furman JM
    Headache; 2004 Apr; 44(4):328-32. PubMed ID: 15109357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool.
    Tepper SJ; Zatochill M; Szeto M; Sheftell F; Tepper DE; Bigal M
    Headache; 2008; 48(10):1419-25. PubMed ID: 19076645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an extended French version of ID Migraine™ as a migraine-screening tool.
    Streel S; Donneau AF; Dardenne N; Hoge A; Bruyère O; Albert A; Guillaume M; Schoenen J
    Cephalalgia; 2015 Apr; 35(5):437-42. PubMed ID: 25115843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the ID Migraine questionnaire for migraine in TMJ and Orofacial Pain Clinic.
    Kim ST; Kim CY
    Headache; 2006 Feb; 46(2):253-8. PubMed ID: 16492234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible role of ID-Migraine in the emergency department: study of an emergency department out-patient population.
    Mostardini C; d'Agostino VC; Dugoni DE; Cerbo R
    Cephalalgia; 2009 Dec; 29(12):1326-30. PubMed ID: 19438919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validity and reliability of the migraine self-questionnaire Alcoi-1995].
    Montiel I; Muñiz R; Asensio M; Ruiz C; Díaz-Marín C; Matías-Guiu J
    Rev Neurol; 1997 Aug; 25(144):1173-7. PubMed ID: 9340140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the pain impact in adults with a chronic pain condition: adaptation and validation of the Pain Impact Questionnaire (PIQ-6) to the Portuguese culture.
    Cavalheiro LM; Gil JA; Gonçalves RS; Pacheco MP; Ferreira PL; Fã L
    Pain Med; 2011 Oct; 12(10):1538-43. PubMed ID: 21883876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of the Migraine Screen Questionnaire (MS-Q).
    Láinez MJ; Domínguez M; Rejas J; Palacios G; Arriaza E; Garcia-Garcia M; Madrigal M
    Headache; 2005; 45(10):1328-38. PubMed ID: 16324165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a german language questionnaire for screening for migraine, tension-type headache, and trigeminal autonomic cephalgias.
    Fritsche G; Hueppe M; Kukava M; Dzagnidze A; Schuerks M; Yoon MS; Diener HC; Katsarava Z
    Headache; 2007 Apr; 47(4):546-51. PubMed ID: 17445104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validation study of an Italian version of the ID Migraine: preliminary results.
    Brighina F; Salemi G; Fierro B; Gasparro A; Balletta G; Aloisio A; La Pegna GB; Randisi G; Saporito V; Calagna G; Lanaia F; Morana R
    J Headache Pain; 2005 Sep; 6(4):216-9. PubMed ID: 16362668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a migraine screening questionnaire in a Colombian university population.
    Rueda-Sánchez M; Díaz-Martínez LA
    Cephalalgia; 2004 Oct; 24(10):894-9. PubMed ID: 15377322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of screening with the brief headache screen compared with a modified IDMigraine.
    Maizels M; Houle T
    Headache; 2008 Mar; 48(3):385-94. PubMed ID: 18028378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The validation of ID Migraine screener in neurology outpatient clinics in Turkey.
    Karli N; Ertas M; Baykan B; Uzunkaya O; Saip S; Zarifoglu M; Siva A;
    J Headache Pain; 2007 Sep; 8(4):217-23. PubMed ID: 17901923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.